|Bid||33.04 x 0|
|Ask||33.14 x 0|
|Day's Range||32.77 - 33.53|
|52 Week Range||32.77 - 33.53|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Here's why Ontrak (NASDAQ: OTRK), Nano-X Imaging (NASDAQ: NNOX), and Zymeworks (NYSE: ZYME) are all strong candidates for stratospheric outperformance by 2025. Will Ontrak overtake Livongo Health? Ontrak is competing with market leader Livongo Health (NASDAQ: LVGO) in a new virtual niche that marries the internet with healthcare knowledge.
Zymeworks (ZYME) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zymeworks Inc. (ZYME) delivered earnings and revenue surprises of 26.74% and 44.72%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?